Christine Margaret Muehlenthaler

Title: Christine Margaret Muehlenthaler: Innovator in Veterinary Vaccination

Introduction

Christine Margaret Muehlenthaler is a prominent inventor based in Ames, IA (US). She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccination methods to control infections in animals. With a total of 9 patents to her name, Muehlenthaler has established herself as a key figure in her area of expertise.

Latest Patents

One of her latest patents focuses on the PCV2 ORF2 protein variant and virus-like particles composed thereof. This invention discloses vaccination methods aimed at controlling PCV2 infection with different subtypes. Specifically, it utilizes PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions that include a PCV2b ORF2 protein. The methods are designed for the treatment or prevention of infections caused by PCV2, addressing both the same subtype and different subtypes. The invention emphasizes the importance of PCV2 subtype b ORF2 proteins that contain at least one mutation in the BC loop, which enhances the expression of the protein compared to the standard PCV2 ORF2 protein.

Career Highlights

Muehlenthaler has worked with notable companies in the veterinary field, including Boehringer Ingelheim Vetmedica GmbH. Her work has significantly impacted the development of effective vaccination strategies for controlling viral infections in animals.

Collaborations

Throughout her career, Muehlenthaler has collaborated with esteemed colleagues such as Luis Alejandro Hernandez and Eric Martin Vaughn. These partnerships have contributed to her innovative research and advancements in veterinary medicine.

Conclusion

Christine Margaret Muehlenthaler is a trailblazer in the field of veterinary vaccination, with a strong portfolio of patents that reflect her dedication to improving animal health. Her innovative work continues to influence the industry and pave the way for future advancements.